Physician
Emergency Medicine
Dr. Steven Le, MD
|
|
Give Review
Steven works in the field of Emergency Medicine. He graduated from New York Medical College. Doctor Steven Le, MD is a published doctor. He has 15 publications published. The most current publication "Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I." Steven accepts Medicare payments and is listed with Medicare.gov.
Publications
- Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
- Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
- Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts.
- Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients.
- Mannose 6-phosphate conjugation is not sufficient to allow induction of immune tolerance to phenylalanine ammonia-lyase in dogs.
- Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.
- Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I.
- The murine cardiac 26S proteasome: an organelle awaiting exploration.
- Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase.
- Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.
- Biochemical characterization of fluorescent-labeled recombinant human alpha-L-iduronidase in vitro.
- Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase.
- Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
- Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid.
Schools
New York Medical College
Doctors Specialties
- Emergency Medicine
Accepted Insurances
- Aetna
- Commercial Insurance Company
- Medicare Advantage PFFS
- Kaiser Permanente
- Medicaid
- Medicare MCR
- Molina
- Tricare
- United Healthcare
- Worker's Compensation WC
Education
-
North Shore-Long Island Jewish Health System -
New York Medical College
Helpful Reviews
Similar Doctors
|
|
Dr. Jay Goldman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul T. Wesley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irina Kalika, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyn S. Aborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric C. Weintz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann M. Arens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan R. Hewitt, MD |
|
|
Dr. Alice M. Kim, DO |
|
|
Dr. Kenneth L. Lum, MD |
|
|
Dr. Tan K. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie J. Schwengels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Wan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark E. Williams, MD
This Doctor is OpenDoctor Recommended.
|